Azathioprine in rheumatoid arthritis. A double-blind, cross over study.
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000505:Alopecia / Q000209:etiology; D000704:Analysis of Variance; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007270:Injections, Intra-Articular; D007840:Latex; D008214:Lymphocytes; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010919:Placebos
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007840:Latex; D010919:Placebos; D001379:Azathioprine